(Q38152470)

29 August 2017

title

Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses (English)

1 reference

29 August 2017

main subject

antimicrobial peptide

1 reference

Kim A Brogden

1

1 reference

29 August 2017

Georgia K Johnson

2

1 reference

29 August 2017

Steven D Vincent

3

1 reference

29 August 2017

Taher Abbasi

4

1 reference

29 August 2017

Shireen Vali

5

1 reference

29 August 2017

publication date

1 October 2013

1 reference

Expert Review of Anti-infective Therapy

29 August 2017

published in

1 reference

29 August 2017

volume

11

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

1097-1113

1 reference

Prevalence of oral lesions among Saudi dental patients

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Prevalence of oral mucosal lesions in elderly people in Santiago, Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Prevalence of periodontitis in adults in the United States: 2009 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

β-Defensins: multifunctional modulators of infection, inflammation and more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Defensins--non-antibiotic use for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Neutrophil-derived defensins as modulators of innate immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Epithelial antimicrobial defence of the skin and intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The novel human beta-defensin-3 is widely expressed in oral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingival crevicular fluid--a MALDI-MS approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Expression of human beta-defensin-3 in gingival epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Concentration and fate of histatins and acidic proline-rich proteins in the oral environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antimicrobial peptides of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antimicrobial peptides and periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Detection and quantitation of forty eight cytokines, chemokines, growth factors and nine acute phase proteins in healthy human plasma, saliva and urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Impalement injuries of the oral cavity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Epithelial antibiotics induced at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Differential expression of antimicrobial peptides in margins of chronic wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Positional differences in the wound transcriptome of skin and oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Differential injury responses in oral mucosal and cutaneous wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Methanogenic Archaea and human periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Defining the normal bacterial flora of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Bacterial diversity within the human subgingival crevice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Subgingival and tongue microbiota during early periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

21 January 2018

Periodontal diseases.

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The microbial challenge in periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Predominant Microbiota Associated with Periodontal Health in the Aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The bacterial etiology of destructive periodontal disease: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Microbial complexes in subgingival plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Oral multispecies biofilm development and the key role of cell-cell distance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Salivary antimicrobial peptide expression and dental caries experience in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Oral antimicrobial peptides and biological control of caries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antimicrobial peptides in periodontal innate defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Toll-like receptor activity in recurrent aphthous ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

CC chemokine ligand 3 and receptors 1 and 5 gene expression in recurrent aphthous stomatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The pathogenesis of oral lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Oral mucosal diseases: mucous membrane pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Localization of antimicrobial peptides human beta-defensins in minor salivary glands with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The minor salivary gland proteome in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the cond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Pattern of expression of beta-defensins in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Expression profile of human beta-defensin 3 in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Carcinoma cell-derived chemokines and their presence in oral fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Retrocyclin, an Antiretroviral θ-Defensin, Is a Lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

A theta-defensin composed exclusively of D-amino acids is active against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human beta-defensin DEFB126 is capable of inhibiting LPS-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The novel human β-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human β-defensin-3 alters, but does not inhibit, the binding of Porphyromonas gingivalis haemagglutinin B to the surface of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Antibiotic-induced Porphyromonas gingivalis LPS release and inhibition of LPS-stimulated cytokines by antimicrobial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

A computer simulation of progesterone and Cox2 inhibitor treatment for preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Off-label use of biologicals in the management of inflammatory oral mucosal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Drug targets in the cytokine universe for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Constitutive release of cytokines by human oral keratinocytes in an organotypic culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Regulation of CXCL9/10/11 in oral keratinocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Expression of human beta-defensins in children with chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

IL-1 beta and PGE2 levels are increased in the saliva of children with Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Anti-lipopolysaccharide activity of histatins, peptides from human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Pro-inflammatory and pro-apoptotic properties of Human Defensin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

Comparison of Salivary Cytokine Levels in Oral Cancer Patients and Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.836059

10.1586/14787210.2013.836059

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference